Prof Thilo Gambichler

vidwan id: 544864

Male

Professor,
Universität Witten/Herdecke

7006633625

Expertise

Pharmacology and Pharmacy

Publications

Total Articles 509

Books 0

Proceedings 0

Publications

Scopus

Citations 13084

h-index 61

CrossRef

Citations 2

h-index 1

Google Scholar

Loading Scholar statistics...

Professional Recognition

No Data Found

There is currently nothing to display here.

Community & Membership

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

Bio

Medicine • Biochemistry, Genetics and Molecular Biology • Immunology and Microbiology, Pharmacology, Toxicology and Pharmaceutics

Personal Details

Male
Professor , Universität Witten/Herdecke

No Data Found

There is currently nothing to display here.

Professor Jul 2017 – Present

Universität Witten/Herdecke

Related Profiles

Experts (5849+)

View All

Assistant Professor

Assistant Professor

Assistant Professor

Physical Director

Assistant Professor

Assistant Professor

Dr Jyothi Alias Jyotsna Baragi

Assistant Professor

Ms Shalini Saini

Assistant Professor

Prof Annette M Bhambal

Professor

SHIVANI SHARMA

N/A

Organisations (7+)

Prof Frank Wappler

Professor

Dr Christoph Schreiber

Dean

Prof Ackermann Ackermann

Professor

Professor

Professor

Professor

Professor

Prof Thilo Gambichler

Professor

Co-Authors (1)

Dr Ragunatha Shivanna

ESIC MEDICAL COLLEGE AND HOSPITAL

Scholarly Work

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

No Data Found

There is currently nothing to display here.

Scholarly Publications

Failure to detect SARS-CoV-2 at RNA and protein level in the sweat of patients with COVID-19

Open Access

Letter

British Journal of Dermatology. Year: 2023. Volume: 188 , Issue: 4 , Pages: 568-570 .

Authors: Gambichler T.;Goesmann S.;Korte V.;Skrygan M.;Harnischfeger F.;Scheel C.H.;Hamdani N.;Budde H.;Sieme M.;Becker J.C.;Schmidt W.

10.1093/bjd/ljac123

Screening for Diabetes Mellitus in Patients with Hidradenitis Suppurativa—A Monocentric Study in Germany

Open Access

Article

International Journal of Molecular Sciences. Year: 2023. Volume: 24 , Issue: 7 .

Authors: Abu Rached N.;Gambichler T.;Ocker L.;Dietrich J.W.;Quast D.R.;Sieger C.;Seifert C.;Scheel C.;Bechara F.G.

10.3390/ijms24076596

Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: A multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG

Open Access

Article

Journal for ImmunoTherapy of Cancer. Year: 2023. Volume: 11 , Issue: 4 .

Authors: Franklin C.;Mohr P.;Bluhm L.;Meier F.;Garzarolli M.;Weichenthal M.;Kähler K.;Grimmelmann I.;Gutzmer R.;Utikal J.;Terheyden P.;Herbst R.;Haferkamp S.;Pfoehler C.;Forschner A.;Leiter U.;Ziller F.;Meiss F.;Ulrich J.;Kreuter A.;Gebhardt C.;Welzel J.;Schilling

10.1136/jitc-2022-005828

Unilateral Blaschkoid-linear verrucous lichen planus under immunotherapy with pembrolizumab

Open Access

Letter

Journal of the European Academy of Dermatology and Venereology. Year: 2023. Volume: 37 , Issue: 5 , Pages: e624-e625 .

Authors: Gambichler T.;Kautz O.;Schacht R.;Boms S.

10.1111/jdv.18759

Real-world outcomes using PD-1 antibodies and BRAF + MEK inhibitors for adjuvant melanoma treatment from 39 skin cancer centers in Germany, Austria and Switzerland

Open Access

Article

Journal of the European Academy of Dermatology and Venereology. Year: 2023. Volume: 37 , Issue: 5 , Pages: 894-906 .

Authors: Schumann K.;Mauch C.;Klespe K.C.;Loquai C.;Nikfarjam U.;Schlaak M.;Akçetin L.;Kölblinger P.;Hoellwerth M.;Meissner M.;Mengi G.;Braun A.D.;Mengoni M.;Dummer R.;Mangana J.;Sindrilaru M.A.;Radmann D.;Hafner C.;Freund J.;Rappersberger K.;Weihsengruber F.;Meis

10.1111/jdv.18779

Two women with primary cutaneous CD4<sup>+</sup> small/medium T-cell lymphoproliferative disorder during pregnancy

Open Access

Letter

Year: 2023. Volume: 48 , Issue: 5 , Pages: 533-535 .

Authors: Gambichler T.;Scheel C.H.;Kock K.;Klapper W.;Doerler M.;Boms S.

10.1093/ced/llad004

Generalized eruptive clear cell acanthomas

Open Access

Article

JEADV Clinical Practice. Year: 2023. Volume: 2 , Issue: 3 , Pages: 605-607 .

Authors: Gambichler T.;Heinzer E.;Kautz O.;Boms S.

10.1002/jvc2.152

Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial

Open Access

Article

The Lancet. Year: 2023. Volume: 402 , Issue: 10404 , Pages: 798-808 .

Authors: Becker J.C.;Ugurel S.;Leiter U.;Meier F.;Gutzmer R.;Haferkamp S.;Zimmer L.;Livingstone E.;Eigentler T.K.;Hauschild A.;Kiecker F.;Hassel J.C.;Mohr P.;Fluck M.;Thomas I.;Garzarolli M.;Grimmelmann I.;Drexler K.;Spillner A.N.;Eckhardt S.;Schadendorf D.;van Ak

10.1016/S0140-6736(23)00769-9

Showing 17 to 24 of 509 results